BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25714016)

  • 21. The Prediction of Clinical Outcome in Hepatocellular Carcinoma Based on a Six-Gene Metastasis Signature.
    Yuan S; Wang J; Yang Y; Zhang J; Liu H; Xiao J; Xu Q; Huang X; Xiang B; Zhu S; Li L; Liu J; Liu L; Zhou W
    Clin Cancer Res; 2017 Jan; 23(1):289-297. PubMed ID: 27449498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yu F; Lu Z; Chen B; Dong P; Zheng J
    Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
    Qiu L; Tang Q; Li G; Chen K
    Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma.
    Toraih EA; Ellawindy A; Fala SY; Al Ageeli E; Gouda NS; Fawzy MS; Hosny S
    Biomed Pharmacother; 2018 Jun; 102():653-669. PubMed ID: 29604585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
    Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
    Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.
    Shi M; Chen MS; Sekar K; Tan CK; Ooi LL; Hui KM
    Eur J Cancer; 2014 Mar; 50(5):928-36. PubMed ID: 24332572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of long non-coding RNAs JPX and XIST is associated with the prognosis of hepatocellular carcinoma.
    Ma W; Wang H; Jing W; Zhou F; Chang L; Hong Z; Liu H; Liu Z; Yuan Y
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):163-170. PubMed ID: 27776968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
    Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
    Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
    Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A
    Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status and future prospects of biomarkers in the diagnosis of hepatocellular carcinoma.
    Zhao Y; Gao Q; Pei L; Wang C; Jin L; Liao F
    Int J Biol Markers; 2017 Oct; 32(4):e361-e369. PubMed ID: 28967065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.
    Poté N; Cauchy F; Albuquerque M; Voitot H; Belghiti J; Castera L; Puy H; Bedossa P; Paradis V
    J Hepatol; 2015 Apr; 62(4):848-54. PubMed ID: 25450201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating LncRNA Serve as Fingerprint for Gestational Diabetes Mellitus Associated with Risk of Macrosomia.
    Lu J; Wu J; Zhao Z; Wang J; Chen Z
    Cell Physiol Biochem; 2018; 48(3):1012-1018. PubMed ID: 30036868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.
    Zhuang LK; Yang YT; Ma X; Han B; Wang ZS; Zhao QY; Wu LQ; Qu ZQ
    Cell Death Dis; 2016 Apr; 7(4):e2203. PubMed ID: 27100897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma.
    El-Tawdi AH; Matboli M; Shehata HH; Tash F; El-Khazragy N; Azazy Ael-S; Abdel-Rahman O
    Mol Diagn Ther; 2016 Jun; 20(3):265-77. PubMed ID: 27113935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma.
    Zhang H; Zhu C; Zhao Y; Li M; Wu L; Yang X; Wan X; Wang A; Zhang MQ; Sang X; Zhao H
    Oncotarget; 2015 Dec; 6(41):43770-8. PubMed ID: 26540467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.
    Niu ZS; Niu XJ; Wang WH
    World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma.
    Wang K; Guo WX; Li N; Gao CF; Shi J; Tang YF; Shen F; Wu MC; Liu SR; Cheng SQ
    PLoS One; 2015; 10(12):e0144934. PubMed ID: 26674525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of long noncoding RNAs for the detection of early stage lung squamous cell carcinoma by microarray analysis.
    Cheng Z; Bai Y; Wang P; Wu Z; Zhou L; Zhong M; Jin Q; Zhao J; Mao H; Mao H
    Oncotarget; 2017 Feb; 8(8):13329-13337. PubMed ID: 28076325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating lncRNAs associated with occurrence of colorectal cancer progression.
    Shi J; Li X; Zhang F; Zhang C; Guan Q; Cao X; Zhu W; Zhang X; Cheng Y; Ou K; Chen Q; Hu S
    Am J Cancer Res; 2015; 5(7):2258-65. PubMed ID: 26328256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.